Catalyst Wire Dossier Catalyst Wire Dossier

semaglutide (tablet formulation)

semaglutide · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for semaglutide (tablet formulation), covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants [Phase 1]

See pricing